Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C

被引:60
作者
Feistritzer, C [1 ]
Sturn, DH [1 ]
Kaneider, NC [1 ]
Djanani, A [1 ]
Wiedermann, CJ [1 ]
机构
[1] Univ Innsbruck, Dept Internal Med, Div Gen Internal Med, A-6020 Innsbruck, Austria
关键词
eosinophils; coagulation; allergy; asthma; protein C;
D O I
10.1067/mai.2003.1609
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Eosinophil infiltration is a characteristic feature of allergic inflammation. Allergic responses are associated with local activation of the coagulation pathway and accumulation of fibrin. Objective: We tested whether protein C and activated protein C (APC), which are endogenous anti-inflammatory coagulation inhibitors, affect eosinophil function. Methods: Eosinophils were from venous blood of healthy donors. Cell migration and apoptosis were studied by using micropore filter assays and fluorometry, respectively. Receptor expression was investigated by means of RT-PCR and SDS-PAGE of immunoprecipitated protein. Results: Protein C and APC had no significant chemotactic effects on eosinophils. Eosinophils pretreated with protein C or APC showed significantly reduced migration toward chemoattractants. No effect of either protein C preparation was seen in eosinophil apoptosis assays. The inhibiting effect on migration was reversed by an antibody against the endothelial protein C receptor (EPCR). Synthesis of EPCR by eosinophils is suggested by demonstration of receptor mRNA expression and detection of metabolically labeled receptor protein. Conclusions: Data suggest that an EPCR is expressed by eosinophils whose activation with protein C or APC arrests directed migration. Protein C-affected eosinophil chemotaxis is a novel thrombin-independent component of the protein C pathway.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 33 条
[1]   ACTIVATION OF THE COAGULATION PATHWAY DURING ONGOING ALLERGIC CUTANEOUS REACTIONS IN HUMANS [J].
ATKINS, PC ;
KAPLAN, AP ;
VONALLMEN, C ;
MOSKOVITZ, A ;
ZWEIMAN, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (02) :552-559
[2]   FIBRIN FORMATION DURING ONGOING CUTANEOUS ALLERGIC REACTIONS - COMPARISON OF RESPONSES TO ANTIGEN AND CODEINE [J].
ATKINS, PC ;
VONALLMEN, C ;
MOSKOVITZ, A ;
VALENZANO, M ;
ZWEIMAN, B .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (04) :956-960
[3]  
Barnes PJ, 1998, PHARMACOL REV, V50, P515
[4]   Asthma - From bronchoconstriction to airways inflammation and remodeling [J].
Bousquet, J ;
Jeffery, PK ;
Busse, WW ;
Johnson, M ;
Vignola, AM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) :1720-1745
[5]   Sol Sherry Lecture in Thrombosis - How thrombin 'talks' to cells - Molecular mechanisms and roles in vivo [J].
Coughlin, SR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (04) :514-518
[6]  
Coughlin SR, 2001, THROMB HAEMOSTASIS, V86, P298
[7]   CHARACTERIZATION OF A FUNCTIONAL THROMBIN RECEPTOR - ISSUES AND OPPORTUNITIES [J].
COUGHLIN, SR ;
VU, TKH ;
HUNG, DT ;
WHEATON, VI .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) :351-355
[8]   Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis [J].
Fujisawa, T ;
Fujisawa, R ;
Kato, Y ;
Nakayama, T ;
Morita, A ;
Katsumata, H ;
Nishimori, H ;
Iguchi, K ;
Kamiya, H ;
Gray, PW ;
Chantry, D ;
Suzuki, R ;
Yoshie, O .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (01) :139-146
[9]  
FUKUDOME K, 1994, J BIOL CHEM, V269, P26486
[10]   Thrombin in the airways of asthmatic patients [J].
Gabazza, EC ;
Taguchi, O ;
Tamaki, S ;
Takeya, H ;
Kobayashi, H ;
Yasui, H ;
Kobayashi, T ;
Hataji, O ;
Urano, H ;
Zhou, H ;
Suzuki, K ;
Adachi, Y .
LUNG, 1999, 177 (04) :253-262